Skip to content
Search

Latest Stories

T20 World Cup to be moved from India to UAE, says Ganguly

THE Twenty20 World Cup will be moved to the United Arab Emirates from India due to the coronavirus pandemic, the country's cricket chief Sourav Ganguly told local media on Monday (28).

The Board of Control for Cricket in India (BCCI) said it had told the world body of its decision to host the event in the UAE in October and November.


"We have officially intimated the ICC (International Cricket Council) that the T20 World Cup can be shifted to the United Arab Emirates," Ganguly, president of the BCCI, told the Press Trust of India news agency.

He added that "the details are being chalked out".

BCCI vice-president Rajeev Shukla said the qualifiers may take place in Oman while the rest of the matches will be at three UAE venues including Dubai, Abu Dhabi and Sharjah.

The ICC had given the BCCI a deadline of the end of June to decide the host country for T20's showpiece event due the Covid situation in India.

India has eased some lockdown restrictions in recent weeks as it emerges from a surge in infections and deaths in April and May.

The BCCI had already moved the suspended Indian Premier League to the UAE in September-October after the T20 tournament was halted on May 4 following a number of players and team officials getting infected with Covid.

(AFP)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less